ZZ Biotech is a company developing biological treatments for ischemic stroke, amyotrophic lateral sclerosis (ALS), and other neurological diseases and wound healing applications, including the treatment of diabetic foot ulcers. It offers 3K3A-APC, a second-generation variant of a naturally occurring human protein for patients suffering from acute ischemic stroke.